BF Biosciences Ltd. (BFBIO): Subscribe to BFBL – Innovative Therapies Leading the Way – By IIS Research

<p></p><ul><li><span style="font-family:Arial, Helvetica, sans-serif;font-size:medium;">BF Biosciences Limited established in 2006 and operational since 2009, built Pakistan's first biotech plant, producing biological medicines for cancer, chronic kidney disease (CKD), and hepatitis C. A joint venture between Ferozsons Laboratories and Argentina&rsquo;s Bag&oacute; Group, BFBL focuses on the import, manufacturing, and distribution of life-saving pharmaceutical products for both local and international markets.</span></li></ul><ul><li><span style="font-family:Arial, Helvetica, sans-serif;font-size:medium;">Originally designed to produce high-margin, low-volume biological drugs, BFBL recognized the growing demand and decided to expand in 2020. The completion of Line II in 2024 has augmented BFBL's capacity to manufacture a diverse a...